Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

Overview of attention for article published in Frontiers in immunology, September 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,324 followers.

Heads up J&J folk. #JandJ

24 Sep 2021

Reply Repost Favourite

New Research: Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol https://t.co/O6c6tjAb66 #immunology

24 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.